Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Acquisitions (2016)

Historic Acquisitions for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Q3 2016 value amounting to $7.7 million.

  • Amphastar Pharmaceuticals' Acquisitions changed N/A to $7.7 million in Q3 2016 from the same period last year, while for Dec 2016 it was $11.7 million, marking a year-over-year change of. This contributed to the annual value of $12.5 million for FY2016, which is 25602.86% up from last year.
  • According to the latest figures from Q3 2016, Amphastar Pharmaceuticals' Acquisitions is $7.7 million.
  • Amphastar Pharmaceuticals' 5-year Acquisitions high stood at $7.7 million for Q3 2016, and its period low was $3.5 million during Q4 2015.